Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
November 06, 2026
Two recent Delaware Court of Chancery decisions illustrate the contractual and fiduciary duty risks associated with earnout provisions in M&A transactions, offering lessons on allocating postclosing control, drafting enforceable earnout covenants and managing executives whose pay depends on the outcome, says Chris Brown at Taft.
-
November 06, 2026
Medical device giant Medtronic Inc. is unlawfully monopolizing the market for a type of medical stapler by blocking competitive product trials and using exclusionary bundling tactics in its deals with hospital customers, according to a rival's complaint in Massachusetts federal court.
-
November 06, 2026
An intellectual property attorney has entered a settlement to resolve his False Claims Act suit against the pharmaceutical company Bausch alleging it fraudulently obtained a patent to block the production of a generic ulcerative colitis medication, Apriso.
-
November 06, 2026
In this week's Taxation With Representation, Marvell Technology buys data center optics maker Lumentum, defense technology company Shield acquires radar company Echodyne, and CVS Health plans to split into two independent, publicly traded companies.
-
November 05, 2026
Johnson & Johnson should pay $60 million for the death of a woman who developed mesothelioma alongside her heart problems after using talc products allegedly contaminated with asbestos, counsel for her family told a Massachusetts state jury during closing arguments Thursday.
See more Life Sciences news